Intratumoural programmed cell death protein expression in 92 patients with atypical fibroxanthoma and pleomorphic dermal sarcoma

被引：0
|
作者：
Gambichler, Thilo [1 ,2 ,3 ,4 ]
Sorescu, Emilia [1 ]
Razeghpour, Fahimeh [1 ]
Becker, Juergen C. [5 ,6 ]
Susok, Laura [1 ,3 ,4 ]
机构：
[1] Ruhr Univ Bochum, Dept Dermatol, Gudrunstr 56, D-44791 Bochum, Germany
[2] Christian Hosp Unna, Dept Dermatol, Unna, Germany
[3] Univ Witten Herdecke, Dortmund Hosp gGmbH, Dept Dermatol, Dortmund, Germany
[4] Univ Witten Herdecke, Fac Hlth, Dortmund, Germany
[5] Univ Duisburg Essen, West German Canc Ctr, Translat Skin Canc Res, DKTK Partner Site Essen Dusseldorf,Dermatol, Essen, Germany
[6] German Canc Res Ctr, Heidelberg, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年
关键词：
D O I：
10.1111/jdv.20421
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden
    Ak, Melike
    Kahraman, Abdullah
    Arnold, Fabian M.
    Turko, Patrick
    Levesque, Mitchell P.
    Zoche, Martin
    Ramelyte, Egle
    Dummer, Reinhard
    GENES, 2021, 12 (07)
  • [42] Pleomorphic Dermal Sarcoma Adverse Histologic Features Predict Aggressive Behavior and Allow Distinction From Atypical Fibroxanthoma
    Miller, Keith
    Goodlad, John R.
    Brenn, Thomas
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (09) : 1317 - 1326
  • [43] Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
    Ricci, Costantino
    De Leo, Antonio
    Dika, Emi
    Lambertini, Martina
    Veronesi, Giulia
    Corti, Barbara
    ACTA HISTOCHEMICA, 2020, 122 (02)
  • [44] Histopathologic Evaluation of Atypical Fibroxanthoma or Pleomorphic Dermal Sarcoma Debulk Specimen from Mohs Surgery: A Requirement for Their Proper Distinction
    Mahmood, Muhammad N.
    DERMATOPATHOLOGY, 2024, 11 (03): : 184 - 191
  • [45] CD140b (PDGF Receptor beta) is a Sensitive and Potentially Useful Marker for Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma
    Gant, Tayler
    Shon, Wonwoo
    LABORATORY INVESTIGATION, 2024, 104 (03) : S523 - S523
  • [46] Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data
    Orholt, Mathias
    Aaberg, Frederik L.
    Abebe, Kiya
    Walsh, S.
    Roenigk, Randall K.
    Venzo, Alessandro
    Schmidt, Grethe
    Klyver, Helle
    Jensen, David H.
    Herly, Mikkel
    Vester-Glowinski, Peter V.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 555 - 562
  • [47] Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"
    Orholt, Mathias
    Eriksson, Frank
    Herly, Mikkel
    Vester-Glowinski, Peter
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (05) : e175 - e176
  • [48] High intratumoral 5-Hydroxymethylcytosine Levels protect against Recurrence in Patients with atypical Fibroxanthoma and pleomorphic Sarcoma
    Weyer-Fahlbusch, S. S.
    Razeghpour, F.
    Abu Rached, N.
    Becker, J. C.
    Susok, L.
    Gambichler, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 : 7 - 7
  • [49] Atypical fibroxanthoma with pseudo-angiomatous features distinguishable from pleomorphic dermal sarcoma and cutaneous angiosarcoma with endothelial markers: The good, bad, and ugly
    Hodson, E.
    Lee-Foltz, M. M.
    Salem, I.
    Sriharan, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S149 - S149
  • [50] Programmed death ligand 1 protein expression, histological tumour differentiation and intratumoural heterogeneity in pulmonary adenocarcinoma
    Tancos, Vladimir
    Grendar, Marian
    Farkasova, Anna
    Hutka, Zdenko
    Micak, Jozef
    Kviatkovska, Zuzana
    Hardman, Timothy C.
    Hardy, Gareth A. D.
    Plank, Lukas
    PATHOLOGY, 2020, 52 (05) : 538 - 545
12345